Cannabics Pharmaceuticals Stock Price History
CNBX Stock | USD 0.01 0 31.58% |
If you're considering investing in Cannabics Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Cannabics Pharmaceuticals stands at 0.01, as last reported on the 25th of January, with the highest price reaching 0.01 and the lowest price hitting 0.01 during the day. Cannabics Pharmaceuticals appears to be out of control, given 3 months investment horizon. Cannabics Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0556, which signifies that the company had a 0.0556 % return per unit of risk over the last 3 months. By analyzing Cannabics Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.71% is justified by implied risk. Please makes use of Cannabics Pharmaceuticals' Standard Deviation of 12.09, risk adjusted performance of 0.0541, and Mean Deviation of 4.33 to double-check if our risk estimates are consistent with your expectations.
Cannabics Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Cannabics |
Sharpe Ratio = 0.0556
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | CNBX | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
12.69 actual daily | 96 96% of assets are less volatile |
Expected Return
0.71 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Cannabics Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cannabics Pharmaceuticals by adding it to a well-diversified portfolio.
Cannabics Pharmaceuticals Pink Sheet Price History Chart
There are several ways to analyze Cannabics Stock price data. The simplest method is using a basic Cannabics candlestick price chart, which shows Cannabics Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 25, 2024 | 0.01 |
Lowest Price | December 17, 2024 | 0.006 |
Cannabics Pharmaceuticals January 25, 2025 Pink Sheet Price Synopsis
Various analyses of Cannabics Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cannabics Pink Sheet. It can be used to describe the percentage change in the price of Cannabics Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cannabics Pink Sheet.Cannabics Pharmaceuticals Price Rate Of Daily Change | 1.32 |
Cannabics Pharmaceuticals January 25, 2025 Pink Sheet Price Analysis
Cannabics Pink Sheet Price History Data
The price series of Cannabics Pharmaceuticals for the period between Sun, Oct 27, 2024 and Sat, Jan 25, 2025 has a statistical range of 0.0 with a coefficient of variation of 9.07. The prices are distributed with arithmetic mean of 0.01. The median price for the last 90 days is 0.01. The company had 1:120 stock split on 12th of May 2022.Open | High | Low | Close | Volume | ||
01/24/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 141,300 | |
01/23/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 12,293 | |
01/22/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 10,200 | |
01/21/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 24.00 | |
01/17/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 51,000 | |
01/16/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 382,200 | |
01/15/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 155,017 | |
01/14/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 7,349 | |
01/13/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 20.00 | |
01/10/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 17,800 | |
01/08/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 4,500 | |
01/07/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 122,697 | |
01/06/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 50,539 | |
01/03/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 50,300 | |
01/02/2025 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
12/31/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 106,700 | |
12/30/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 10,700 | |
12/27/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 10,100 | |
12/26/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 456,600 | |
12/24/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 29,900 | |
12/23/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 211,400 | |
12/20/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 40,200 | |
12/19/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
12/18/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 101,300 | |
12/17/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 121,117 | |
12/16/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 330,205 | |
12/13/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 90.00 | |
12/12/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 50,400 | |
12/11/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 60,300 | |
12/10/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 334,500 | |
12/09/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 19,800 | |
12/06/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 563,400 | |
12/05/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 80,200 | |
12/04/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1,500 | |
12/03/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 3,100 | |
12/02/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 47,900 | |
11/29/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 15,000 | |
11/27/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 13,400 | |
11/26/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
11/25/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 162.00 | |
11/22/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 70,300 | |
11/21/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
11/20/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1.00 | |
11/19/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 3,700 | |
11/18/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 35,149 | |
11/15/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 800.00 | |
11/14/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 5,300 | |
11/13/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 76,000 | |
11/12/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 38,500 | |
11/11/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 201,000 | |
11/08/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 3,200 | |
11/07/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 76,700 | |
11/06/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 97,400 | |
11/05/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 119,400 | |
11/04/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 204,100 | |
11/01/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 515,000 | |
10/31/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 152.00 | |
10/30/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 25,000 | |
10/29/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 86,300 | |
10/28/2024 | 0.01 | 0.01 | 0.01 | 0.01 | 1,379,200 | |
10/25/2024 | 0.01 | 0.02 | 0.01 | 0.01 | 37,200 |
About Cannabics Pharmaceuticals Pink Sheet history
Cannabics Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cannabics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cannabics Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cannabics Pharmaceuticals stock prices may prove useful in developing a viable investing in Cannabics Pharmaceuticals
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. Cnbx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
Cannabics Pharmaceuticals Pink Sheet Technical Analysis
Cannabics Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
All Next | Launch Module |
Cannabics Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cannabics Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cannabics Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cannabics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0541 | |||
Jensen Alpha | 0.5578 | |||
Total Risk Alpha | (0.02) | |||
Treynor Ratio | 0.3884 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Cannabics Pink Sheet Analysis
When running Cannabics Pharmaceuticals' price analysis, check to measure Cannabics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannabics Pharmaceuticals is operating at the current time. Most of Cannabics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cannabics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannabics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cannabics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.